Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given written consent to participate
- People who have been diagnosed with endometrial cancer that has been confirmed through laboratory testing of tissue samples
- People who have had molecular and genetic testing done on their tumor (looking at specific markers including POLE mutation, p53 abnormalities, MMRd/MSI-H, and NSMP)
- People who have data available on the specific characteristics of their tumor tissue
- People who have undergone a procedure called sentinel node mapping (a technique used to identify key lymph nodes near the tumor)
- People who have results available showing whether their sentinel nodes were affected by cancer or not
Who may not be able to join:
- People whose endometrial cancer has been classified as Stage IVB (the most advanced stage, where cancer has spread to distant parts of the body)
- People who have withdrawn their consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Giorgio Bogani, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phone: 917-275-6975
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
positive nodes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.